Effectiveness of antiepileptic therapy in patients with PCDH19 mutations

Jan Lotte, Thomas Bast, Peter Borusiak, Antonietta Coppola, J. Helen Cross, Petia Dimova, Andras Fogarasi, Irene Graness, Renzo Guerrini, Helle Hjalgrim, Reinhard Keimer, Christian M. Korff, Gerhard Kurlemann, Steffen Leiz, Michaela Linder-Lucht, Tobias Loddenkemper, Christine Makowski, Christian Muehe, Joost Nicolai, Marina NikanorovaSimona Pellacani, Sunny Philip, Susanne Ruf, Ivan Sanchez Fernandez, Kurt Schlachter, Pasquale Striano, Biayna Sukhudyan, Deyana Valcheva, R.J. Vermeulen, Tanja Weisbrod, Bernd Wilken, Philipp Wolf, Gerhard Kluger

Research output: Contribution to journalArticleAcademicpeer-review

7 Citations (Scopus)
Original languageEnglish
Pages (from-to)106-110
JournalSEIZURE-EUROPEAN JOURNAL OF EPILEPSY
Volume35
DOIs
Publication statusPublished - Feb 2016

Keywords

  • PCDH19 mutation
  • Epilepsy
  • Antiepileptic drugs
  • Treatment
  • Long-term effectiveness

Cite this

Lotte, J., Bast, T., Borusiak, P., Coppola, A., Cross, J. H., Dimova, P., Fogarasi, A., Graness, I., Guerrini, R., Hjalgrim, H., Keimer, R., Korff, C. M., Kurlemann, G., Leiz, S., Linder-Lucht, M., Loddenkemper, T., Makowski, C., Muehe, C., Nicolai, J., ... Kluger, G. (2016). Effectiveness of antiepileptic therapy in patients with PCDH19 mutations. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 35, 106-110. https://doi.org/10.1016/j.seizure.2016.01.006